Table 2 Demographic characteristics of the patients with COPD using inhaled corticosteroids
Variables | COPD with medium dose of ICS | COPD with high dose of ICS | pvalue |
|---|---|---|---|
| Â | (n = 71) | (n = 54) | Â |
Age | 64.1 ± 25.2 | 68.5 ± 24.4 | 0.36 |
Gender (M/F) | 66/5 | 51/3 | 0.48 |
smoking (pack-years) | 26.4 ± 13.6 | 25.1 ± 11.1 | 0.41 |
Lung function | Â | Â | Â |
   mild obstruction | 0 | 0 |  |
   moderate obstruction | 31 (43.7%) | 10 (18.5%) | 0.04* |
   severe obstruction | 31 (43.7%) | 23 (42.6%) | 0.90 |
   very severe obstruction | 9 (18.3%) | 21 (31.5%) | 0.01* |
Pneumonia | 13 (18.3%) | 7 (12.9%) | 0.47 |
Hospitalization | 2 (2.8%) | 2 (3.7%) | 0.78 |
C-reactive Protein (CRP) (mg/L) | 4.8 ± 2.4 | 4.7 ± 2.7 | 0.62 |
Placenta Growth Factor (PlGF)(pg/L) | 49.2 ± 23.5 | 51.3 ± 20.8 | 0.56 |